Panagora Asset Management Inc Xeris Biopharma Holdings, Inc. Transaction History

Panagora Asset Management Inc

  • $20.5 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024
SELL
$1.47 - $2.36 $161,526 - $259,321
-109,882 Reduced 43.92%
140,318 $329,000
Q3 2023

Oct 31, 2023
SELL
$1.8 - $2.69 $67,320 - $100,606
-37,400 Reduced 13.0%
250,200 $465,000
Q2 2023

Aug 11, 2023
BUY
$1.82 - $2.98 $523,432 - $857,048
287,600 New
287,600 $753,000

Others Institutions Holding XERS

# of Institutions
141
Shares Held
59.9M
Call Options Held
148K
Put Options Held
45.7K
View Full List

About Xeris Biopharma Holdings, Inc.

XERS Quotes by TradingView
  • Ticker XERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,956,992
  • Market Cap $416M
  • Description
  • Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...
More about XERS
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email